Article Text

Download PDFPDF

Percutaneous thoracostomy for traumatic hemothoraces: a call for research
  1. Marc de Moya
  1. Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
  1. Correspondence to Dr Marc de Moya; mdemoya{at}mcw.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

McLauchlan and others report a case series of nine trauma patients with hemothoraces that were drained with a percutaneous 14Fr drain and lavaged.1 They demonstrate the feasibility of performing thoracic lavage via the 14Fr drain. In doing so, they were able to, in theory, leverage the benefits of a smaller percutaneous tube (less pain)2 with the benefits of lavage (lower incidence of retained hemothoraces).3 It is the first report of combining the techniques and shows promise. There are a number of questions that it raises which certainly will need to be evaluated with a larger prospective cohort. The type of percutaneous tube used was one of the pigtail variety which may need to be evaluated in comparison to its straight tube variety. The timing of the lavage and the possible need for a repeat lavage will need to be addressed. There may be a role for lavage with a pigtail that is image guided for empyema or the installation of lytic therapy. Of note, the authors were able to quantify the hemothoraces in some of the patients using the Mergo formula calculated on a CT scan prior to tube placement. The utilization of a more objective measure of the volume of the hemothorax is another evolving field that warrants a closer examination.

Overall, the authors offer a feasible technique for lavaging the chest with less pain and may be a promising approach to the stable patient with a traumatic hemothorax. I look forward to future studies that explore the many questions regarding the management of hemothoraces that remain.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors MD is the sole author.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles